Peregrine Capital Management LLC View Ray, Inc. Transaction History

Peregrine Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 26, 2023	BUY	$3.28 - $4.81 $116,384 - $170,673	35,483 Added 3.06%	1,196,945 $4.14 Million
Q4 2022 Jan 10, 2023	SELL	$3.65 - $4.82 $128,786 - $170,068	-35,284 Reduced 2.95%	1,161,462 $5.2 Million
Q3 2022 Oct 26, 2022	SELL	$2.66 - $3.97 $176,225 - $263,012	-66,250 Reduced 5.25%	1,196,746 $4.36 Million
Q2 2022 Jul 20, 2022	SELL	$2.42 - $4.05 $2,640 - $4,418	-1,091 Reduced 0.09%	1,262,996 $3.35 Million
Q1 2022 Apr 27, 2022	SELL	$3.45 - $5.83 $312,528 - $528,128	-90,588 Reduced 6.69%	1,264,087 $4.96 Million
Q4 2021 Jan 31, 2022	BUY	$4.89 - $7.59 $6.62 Million - $10.3 Million	1,354,675 New	1,354,675 $7.46 Million

645K

50K

30K

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Peregrine Capital Management LLC with notifications on news.